Citation: Wang Zhanlin, Li Ruyi, Qian Huimin, Yao Changsheng. Effect of Temperature on N-Heterocyclic Carbene-Catalyzed[3+3] Annulation of α-Bromoenal with Enaminone[J]. Chinese Journal of Organic Chemistry, 2019, 39(7): 2075-2083. doi: 10.6023/cjoc201901052
温度对氮杂环卡宾催化下α-溴代烯醛与烯胺酮的[3+3]环化反应影响
-
关键词:
- 氮杂环卡宾(NHC)
- / α-溴代烯醛
- / 烯胺酮
- / [3+3]环化
English
Effect of Temperature on N-Heterocyclic Carbene-Catalyzed[3+3] Annulation of α-Bromoenal with Enaminone
-
Key words:
- N-heterocyclic carbene (NHC)
- / α-bromoenal
- / enaminone
- / [3+3]annulation
-
通过改变反应条件来构建不同的骨架结构是有机合成的研究热点之一[1].其中, 温度对于反应的影响十分显著, 通过对温度的调控来区域选择性地合成具有不同结构的化合物, 也是化学家关注的重点之一. 2018年, Wu课题组[2]发现了一种合成2-氨基噻吩或噻吩并[2, 3c]异噻唑化合物的新方法, 其中温度控制的环化是控制该过程化学选择性的关键之处(Scheme 1a).同年, Reiser课题组[3]报道了通过温度控制选择性C—S或C—C键的构建.在光催化和室温条件下, 利用未活化的杂环芳基与芳基磺酰氯进行反应, 实现C—S键的构建.当提升温度后, 芳基磺酰氯底物脱去SO2, 得到芳基化产物, 实现了C—C键的构建.因此, 通过温度的调控以优异的化学选择性得到了芳基化或芳基磺酰化产物(Scheme 1b).最近, Li课题组[4]报道了金催化炔丙胺和2-丁炔酸酯在温度不高于120 ℃时反应, 得到吡咯并[b]环丁烯化合物; 当升高温度至150 ℃, 得到二氢-1H-氮杂䓬衍生物(Scheme 1c).这些现象说明, 温度对于有机反应的化学选择性和区域选择性有着至关重要的影响.
图式 1
近几十年来, 在有机小分子催化领域中, 氮杂环卡宾(N-heterocyclic carbene, NHC)已经成为热门的研究方向之一[5]. NHC可以活化的底物从起初的醛拓展到迈克尔受体、烯酮和羧酸衍生物等[6].化学家们投入了大量精力研究酰基阴离子的等价物(Breslow中间体)、烯醇负离子、高烯醇负离子等NHC键合中间体的形成和反应活性. α, β-不饱和酰基唑阳离子是NHC催化化学中的重要中间体之一[7].它可以通过NHC与烯醛、炔醛、α-溴代烯醛、α, β-不饱和酰基卤或者α, β-不饱和羧酸酯反应而形成(图 1)[8].该中间体具有1, 3-双亲电位点, 可以和1, n-双亲核试剂进行[3+n]环化反应, 构建一系列杂环骨架. 2012年, 我们课题组[9]实现了NHC催化下α-溴代烯醛与烯胺酮通过[3+3]环化反应, 合成了一系列具有潜在的生物活性的喹啉衍生物(Scheme 2).基于对高光学纯度化合物的巨大需求, 设想通过手性NHC催化该反应, 为喹啉衍生物的不对称合成提供新方法.然而该反应在80 ℃下进行时, 对映选择性并不理想.随后, 尝试通过降温来提高反应的光学产率.意外的是, 当温度降至35 ℃时, 反应给出稠合二氢吡喃酮衍生物, 而并非是目标的喹啉类衍生物.研究温度对该反应的影响不仅能够丰富和发展NHC催化化学, 而且可以为具有重要生物活性的稠合二氢吡喃酮骨架构建提供新思路[10].为了延续我们课题组在NHC催化串联反应方面的研究[11], 本文将报道NHC催化下温度对α-溴代烯醛与烯胺酮的[3+3]环化反应影响.
图 1
图式 2
1. 结果与讨论
1.1 反应条件的优化
我们以α-溴代肉桂醛(1a)与烯胺酮(2a)的反应作为模板, 对催化剂、碱、溶剂及温度等反应条件进行了筛选, 并将结果列入表中(表 1).
表 1

Entry NHC Base Solvent T/℃ Yieldb/% of 3a Yieldb/% of 4a 1 None Cs2CO3 Toluene 25 — — 2 A Cs2CO3 Toluene 25 Trace — 3 B Cs2CO3 Toluene 25 40 — 4 C Cs2CO3 Toluene 25 14 — 5 D Cs2CO3 Toluene 25 21 — 6 E Cs2CO3 Toluene 25 Trace — 7 B K2CO3 Toluene 25 32 — 8 B CH3COONa Toluene 25 — — 9 B KOBu-t Toluene 25 20 — 10 B DABCO Toluene 25 — — 11 B DBU Toluene 25 — — 12 B Et3N Toluene 25 — — 13 B Cs2CO3 THF 25 55 — 14 B Cs2CO3 CH2Cl2 25 12 — 15 B Cs2CO3 1, 4-Dixoane 25 Trace — 16 B Cs2CO3 Toluene 15 53 — 17 B Cs2CO3 Toluene 35 67 — 18 B Cs2CO3 Toluene 45 41 Trace 19 B Cs2CO3 Toluene 55 29 41 a All reactions were performed by using 1.2 equiv. of 1a (0.24 mmol), 1.0 equiv. of 2a (0.2 mmol) in the presence of NHC (20 mol%), and 120 mol% of base in solvent (3 mL) under N2. b Isolated yield. 首先, 对催化剂进行了筛选.当不加催化剂时, 没有监测到任何产物的生成(表 1, Entry 1).接着, 对催化剂种类进行了筛选, 结果发现咪唑盐B可以催化该反应, 并以40%的产率得到3a, 但是没有发现4a的形成(表 1, Entry 3)[9].随后, 以B为催化剂, 研究了碱和溶剂对反应产利率的影响.结果显示在Cs2CO3为碱、四氢呋喃(THF)为溶剂时反应效果最理想(表 1, Entries 7~15).最后, 对反应体系的温度进行了评估, 发现该反应的最佳反应温度为35 ℃(表 1, Entries 16~19).当温度升高至45 ℃时, 有微量的4a生成; 当温度达到55 ℃时, 可以同时分离到3a (29%)和4a (41%)两种产物, 并且, 4a的产率随着温度升高而升高.最终, 确定了合成稠合二氢吡喃酮化合物的最佳反应条件为:咪唑盐B作催化剂, Cs2CO3为碱, 甲苯为溶剂, 反应温度设置为35 ℃.
在最佳反应条件下, 对反应的底物适用范围进行了探究.首先, 对含有不同取代基的α-溴代烯醛进行测试, 结果表明当苯环上连有吸电子取代基(4-Br)或供电子取代基(4-CH3, 4-OCH3), 或者将其改为杂环基(噻吩、呋喃)时, 反应都能以理想的产率给出目标产物(表 2, 3a~3f), 但是强吸电子取代的溴代肉桂醛不能参与该反应.此外, 将R1改为脂肪基, 反应也不能进行.随后, 为了探究该反应对于底物的耐受性, 将R3变换为带有供电子基(4-CH3)或者吸电子基(4-Cl, 4-NO2)的苯环, 该方法同样适用, 并以较优异的产率给出相应的环化产物(表 2, 3e~3o).另外, 当R2为H时, 该反应也能顺利发生, 并以较高产率得到目标产物(表 2, 3p~3q).这些结果凸显了该方法具有广泛的底物范围.
表 2

Entry R1 R2 R3 Product Yield a/% 1 Ph Me Ph 3a 75 2 4-CH3C6H4 Me Ph 3b 94 3 4-OCH3C6H4 Me Ph 3c 88 4 4-BrC6H4 Me Ph 3d 73 5 Thienyl Me Ph 3e 79 6 Furanyl Me Ph 3f 70 7 4-CH3C6H4 Me 4-CH3C6H4 3g 96 8 4-CH3C6H4 Me 4-ClC6H4 3h 85 9 4-BrC6H4 Me 4-CH3C6H4 3i 80 10 Ph Me 4-NO2C6H4 3j 66 11 Thienyl Me 4-CH3C6H4 3k 81 12 Ph Me 4-CH3C6H4 3l 92 13 Ph Me 4-OCH3C6H4 3m 71 14 4-BrC6H4 Me 4-ClC6H4 3n 65 15 Thienyl Me 4-ClC6H4 3o 72 16 Ph H Ph 3p 76 17 4-CH3C6H4 H Ph 3q 85 a All reactios were performed by using 1.2 equiv. of 1 (0.24 mmol), 1.0 equiv. of 2 (0.2 mmol), in the presence of B (20 mol%), and 120 mol% of Cs2CO3 in toluene (3 mL) at 35 ℃ under N2. b Isolated yield by column chromatography. 随后, 对稠合吡喃酮的不对称合成也进行了初步的探索.结果表明, 在采用手性茚骨架的三唑卡宾盐A作为催化剂, 碳酸钾作为碱, 甲苯作为溶剂时, 该反应可以顺利进行, 并且以72%的产率和65%的ee值得到目标产物(Scheme 3).更加深入的探索正在进行中, 结果请见后续报道.
图式 3
此外, 以达米酮或1, 3-环己二酮代替烯胺酮在相同条件下合成类似的稠合吡喃衍生物, 发现该反应根本不能发生(Scheme 4).
图式 4
所有产物经过了NMR、IR和HRMS的表征.为了进一步确证产物的结构, 我们培养了化合物3a的单晶, 其结构见图 2[12].
图 2
根据产物的结构, 我们推测了该反应的可能机理(图 3)[13].以化合物3a的合成为例, 卡宾前体盐B去质子后形成的自由卡宾与α-溴代肉桂醛反应形成Breslow中间体.该中间体经过a3-d3极性反转后, 脱去溴离子形成α, β-不饱和酰基阳唑离子Ⅰ.它与烯胺酮可以经过两种途径转化为目标化合物.第一种途径为:底物2a与中间体Ⅰ发生Michael加成, 得到加成中间体Ⅲ, 接着烯醇互变得到中间体Ⅳ, 再经过分子内酯化, 脱去卡宾得到目标产物.第二种途径为:底物2a与中间体Ⅰ先进行1, 2-加成反应得到中间体Ⅱ, 接着经过克莱森重排得到中间体Ⅳ.接下来的路径与途径1相似, 最后经过分子内酯化, 脱去卡宾, 得到目标产物3a.
图 3
2. 结论
温度对NHC催化的α, β-不饱和醛与烯胺酮的[3+3]环化反应的区域选择性有着至关重要的影响.通过降低反应温度, 实现了稠合吡喃酮区域专一性合成.该方法具有反应条件温和、产率高、操作简便等优点, 为稠合吡喃酮高效构建提供了新方法.
3. 实验部分
3.1 仪器与试剂
所需溶剂均已做无水处理.柱层析所用石油醚需蒸馏并收集60~90 ℃馏分, 使用100~200目硅胶.核磁共振仪: 1H NMR测试频率Bruker DPX 400 MHz, 13C NMR测试频率Bruker DPX 100 MHz, 并以CDCl3为溶剂, 以四甲基硅烷(TMS)为内标; HRMS谱由micrOTOF-QII高分辨质谱仪测定; 熔点测定使用XT-5型显微熔点测定仪.底物1和2的合成请查阅参考文献[14], α, β-不饱和醛及其他实验药品在安耐吉、北京伊诺凯科技有限公司、网化商城等公司购买.
3.2 实验方法
向干燥的10 mL Schlenk反应管中加入反应物1a (0.24 mmol)和2a (0.20 mmol), 咪唑催化剂前体B (0.04 mmol, 17.0 mg), Cs2CO3 (0.40 mmol, 130.3 mg)的混合物, 通入氮气置换空气, 随后使用注射器将3.0 mL干燥甲苯注入Schlenk管.将反应体系置于35 ℃, 搅拌反应.薄层色谱(TLC)检测反应结束后, 减压蒸馏除去溶剂, 柱色谱分离产物[洗脱剂: V(石油醚):V(乙酸乙酯)=7:1], 得到黄色或淡黄色固体3a~3q.
(E)-7, 7-二甲基-4-苯基-5-(苯基亚氨基)-3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3a):淡黄色固体, 产率75%. m.p. 135.6~137.6 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.34~7.23 (m, 7H), 7.04 (t, J=7.4 Hz, 1H), 6.58 (d, J=8.1 Hz, 2H), 4.63 (d, J=7.3 Hz, 1H), 3.06 (dd, J=16.0, 7.5 Hz, 1H), 2.97 (d, J=15.9 Hz, 1H), 2.48 (d, J=17.8 Hz, 1H), 2.40 (d, J=17.8 Hz, 1H), 2.20 (d, J=15.5 Hz, 1H), 2.12 (d, J=15.5 Hz, 1H), 1.07 (s, 3H), 1.02 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.4, 162.9, 157.4, 151.3, 141.4, 128.9, 128.8, 127.1, 126.9, 123.0, 119.3, 115.9, 41.2, 40.8, 36.7, 34.7, 31.7, 28.4, 28.1; IR (KBr) ν: 1780, 1670, 1623, 1591, 1485, 1380, 1216, 1169, 1108, 957, 857, 764 cm-1. HRMS (ESI) calcd for C23H23O2NNa [M+Na]+ 368.1626, found 368.1627.
(E)-7, 7-二甲基-5-(苯基亚氨基)-4-(对甲苯基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3b):淡黄色固体, 产率94%. m.p. 90.1~92.8 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.24~7.28 (m, 2H), 7.08~7.14 (m, 4H), 7.00~7.04 (m, 1H), 6.56 (dd, J=8.4, 1.2 Hz, 2H), 4.57 (d, J=7.2 Hz, 1H), 3.01 (dd, J=16.0, 7.2 Hz, 1H), 2.92 (d, J=16.0, 1H), 2.44 (d, J=17.6 Hz, 1H), 2.36 (d, J=17.6, 1H), 2.31 (s, 3H), 2.17 (d, J=15.6 Hz, 1H), 2.08 (d, J=15.6 Hz, 1H), 1.04 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.6, 162.9, 157.2, 151.3, 138.4, 136.6, 129.5, 128.8, 126.8, 123.0, 119.3, 116.1, 41.2, 40.8, 36.8, 34.2, 31.6, 28.4, 28.0, 21.0; IR (KBr) v: 1789, 1772, 1662, 1627, 1507, 1380, 1186, 1119. 822, 693, 668, 527 cm-1. HRMS (ESI) calcd for C24H25O2NNa [M+Na]+ 382.1783, found 382.1809.
(E)-4-(4-甲氧基苯基)-7, 7-二甲基-5-(苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3c):淡黄色固体, 产率88%. m.p. 106.5~107.1 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.26 (d, J=7.8 Hz, 2H), 7.16 (d, J=8.6 Hz, 2H), 7.02 (t, J=7.4 Hz, 1H), 6.82 (d, J=8.7 Hz, 2H), 6.56 (d, J=7.5 Hz, 2H), 4.55 (d, J=7.1 Hz, 1H), 3.77 (s, 3H), 3.00 (dd, J=16.0, 7.4 Hz, 1H), 2.91 (d, J=14.4 Hz, 1H), 2.44 (d, J=17.8 Hz, 1H), 2.36 (d, J=17.8 Hz, 1H), 2.17 (d, J=15.5 Hz, 1H), 2.09 (d, J=15.5 Hz, 1H), 1.04 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 166.75, 163.85, 159.04, 157.44, 143.61, 141.10, 128.99, 127.35, 126.79, 125.07, 119.58, 115.29, 41.80, 40.82, 36.75, 34.98, 31.89, 28.28, 28.13; IR (KBr) ν: 1781, 1770, 1652, 1637, 1501, 1340, 1176, 1110. 830, 690, 661, 523 cm-1. HRMS (ESI) calcd for C24H26O3N [M+H]+ 376.1907, found 376.1907.
(E)-4-(4-溴苯基)-7, 7-二甲基-5-(苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3d):黄色固体, 产率73%. m.p. 134.5~134.9 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.41 (d, J=8.5 Hz, 2H), 7.34~7.22 (m, 2H), 7.12 (d, J=8.4 Hz, 2H), 7.10~6.95 (m, 1H), 6.54 (dd, J=8.3, 1.1 Hz, 2H), 4.56 (d, J=7.6 Hz, 1H), 3.03 (dd, J=16.1, 7.7 Hz, 1H), 2.90 (d, J=14.5 Hz, 1H), 2.44 (d, J=17.8 Hz, 1H), 2.37 (d, J=17.9 Hz, 1H), 2.17 (d, J=15.6 Hz, 1H), 2.09 (d, J=15.6 Hz, 1H), 1.04 (s, 3H), 0.98 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.1, 162.7, 157.6, 151.0, 140.6, 131.9, 128.9, 128.7, 123.2, 120.9, 119.2, 115.5, 41.1, 40.8, 36.4, 34.3, 31.6, 28.3, 28.1; IR (KBr) ν: 1790, 1662, 1622, 1592, 1488, 1408, 1376, 1228, 1159, 1090, 1008, 957, 857, 771, 695 cm-1. HRMS (ESI) calcd for C23H22O2NBrNa [M+Na]+ 446.0732, found 446.0736.
(E)-7, 7-二甲基-5-(苯基亚氨基)-4-(噻吩-2-基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3e):黄色固体, 产率79%. m.p. 121.5~121.8 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.30~7.34 (m, 2H), 7.16 (dd, J=4.4, 1.6 Hz, 1H), 7.05~7.09 (m, 1H), 6.90~6.92 (m, 2H), 6.72 (dd, J=8.4, 1.2 Hz, 2H), 4.85 (d, J=6.8 Hz, 1H), 3.20 (d, J=16.0, 1H), 3.02 (dd, J=16.0, 7.2 Hz, 1H), 2.34 (s, 2H), 2.17 (s, 2H), 1.03 (s, 3H), 0.98 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.2, 162.9, 157.2, 151.1, 144.4, 128.9, 126.6, 124.5, 123.4, 123.2, 119.4, 116.4, 41.1, 40.7, 36.0, 31.7, 30.0, 28.3, 28.1; IR (KBr) ν: 1783, 1659, 1608, 1591, 1494, 1484, 1380, 1219, 1169, 1115, 703 cm-1. HRMS (ESI) calcd for C21H21O2NNaS [M+Na]+374.1191, found 374.1201.
(E)-4-(呋喃-2-基)-7, 7-二甲基-5-(苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3f):淡黄色固体, 产率70%. m.p. 108.1~108.5 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.30 (t, J=7.8 Hz, 2H), 7.05 (t, J=7.4 Hz, 1H), 6.63 (d, J=7.3 Hz, 2H), 6.18 (d, J=3.2 Hz, 1H), 6.06 (d, J=3.2 Hz, 1H), 4.66 (d, J=7.0 Hz, 1H), 3.11 (d, J=17.5 Hz, 1H), 2.90 (dd, J=16.1, 7.3 Hz, 1H), 2.39 (d, J=17.8 Hz, 1H), 2.33 (d, J=18.0 Hz, 1H), 2.16 (s, 2H), 1.03 (s, 3H), 1.00 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 166.75, 163.85, 159.04, 157.44, 143.61, 141.10, 128.99, 127.35, 126.79, 125.07, 119.58, 115.29, 41.80, 40.82, 36.75, 34.98, 31.89, 28.28, 28.13; IR (KBr) ν: 1773, 1669, 1601, 1540, 1504, 1492, 1381, 1211, 1179, 1105, 699 cm-1. HRMS (ESI) calcd for C21H22O3N [M+H]+ 336.1594, found 336.1595.
(E)-7, 7-二甲基-4-(对甲苯基)-5-(对甲苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3g):淡黄色固体, 产率96%. m.p. 99.2~99.8 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.06~7.14 (m, 6H), 6.47 (d, J=8.0 Hz, 2H), 4.58 (d, J=7.2 Hz, 1H), 3.00 (dd, J=16.0, 7.2 Hz, 1H), 2.91 (d, J=15.6 Hz, 1H), 2.27~2.46 (m, 8H), 2.19 (d, J=15.2 Hz, 1H), 2.10 (d, J=15.2 Hz, 1H), 1.03 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.7, 162.9, 156.9, 148.7, 138.4, 136.5, 132.4, 129.4, 129.4, 126.8, 119.3, 116.2, 41.1, 40.8, 36.8, 34.2, 31.6, 28.5, 28.0 21.0, 20.8; IR (KBr) ν: 1789, 1739, 1669, 1622, 1503, 1380, 1231, 1176, 1118, 1037, 969, 855, 625 cm-1. HRMS (ESI) calcd for C25H27O2NNa [M+Na]+ 396.1939, found 396.1946.
(E)-5-((4-氯苯基)亚氨基)-7, 7-二甲基-4-(对甲苯基)-3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3h):黄色固体, 产率85%. m.p. 115.7~116.1 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.24~7.18 (m, 2H), 7.10 (s, 4H), 6.49 (d, J=9.4 Hz, 2H), 4.53 (d, J=7.3 Hz, 1H), 3.00 (dd, J=16.0, 7.4 Hz, 1H), 2.91 (d, J=14.2 Hz, 1H), 2.45 (d, J=17.8 Hz, 1H), 2.37 (d, J=16.8 Hz, 1H), 2.30 (s, 3H), 2.15 (d, J= 15.5 Hz, 1H), 2.07 (d, J=15.5 Hz, 1H), 1.04 (s, 3H), 1.00 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.4, 163.7, 157.7, 149.8, 138.2, 136.7, 129.5, 128.9, 128.3, 126.7, 120.7, 115.9, 41.2, 40.8, 36.8, 34.3, 31.7, 28.4, 28.1, 21.0; IR (KBr) ν: 1787, 1661, 1621, 1585, 1481, 1379, 1226, 1181, 1115, 1034, 971, 860, 853, 817 cm-1. HRMS (ESI) calcd for C24H24O2NClNa [M+Na]+ 416.1393, found 416.1417.
(E)-4-(4-溴苯基)-7, 7-二甲基-5-(对甲苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3i):黄色固体, 产率80%. m.p. 132.8~133.3 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.40 (d, J=8.5 Hz, 2H), 7.12 (d, J=8.4 Hz, 2H), 7.07 (d, J=7.9 Hz, 2H), 6.45 (d, J=8.2 Hz, 2H), 4.56 (d, J=7.7 Hz, 1H), 3.02 (dd, J=16.1, 7.7 Hz, 1H), 2.90 (d, J=16.1 Hz, 1H), 2.43 (d, J=17.8 Hz, 1H), 2.36 (d, J=18.0 Hz, 1H), 2.31 (s, 3H), 2.18 (d, J=15.5 Hz, 1H), 2.10 (d, J=15.5 Hz, 1H), 1.03 (s, 3H), 0.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.1, 162.7, 157.3, 148.4, 140.6, 132.6, 131.9, 129.5, 128.7, 120.9, 119.2, 115.6, 41.0, 40.8, 36.4, 34.2, 31.6, 28.3, 28.1, 20.8; IR (KBr) ν: 1786, 1647, 1618, 1479, 1421, 1377, 1202, 1149, 1107, 1087, 1044, 870, 853, 813 cm-1. HRMS (ESI) calcd for C24H24O2BrNNa [M+Na]+ 460.0888, found 460.0876.
(E)-7, 7-二甲基-5-((4-硝基苯基)亚氨基)-4-苯基- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3j):产率66%. m.p. 129.7~130.4 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.15 (d, J=8.9 Hz, 2H), 7.39~7.14 (m, 6H), 6.62 (d, J=8.9 Hz, 2H), 4.52 (d, J=7.4 Hz, 1H), 3.05 (dd, J=16.1, 7.6 Hz, 1H), 2.95 (d, J=14.5 Hz, 1H), 2.50 (d, J=18.0 Hz, 1H), 2.43 (d, J=18.9 Hz, 1H), 2.12 (d, J=15.6 Hz, 1H), 2.07 (d, J=15.6 Hz, 1H), 1.07 (s, 3H), 1.03 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 166.75, 163.85, 159.04, 157.44, 143.61, 141.10, 128.99, 127.35, 126.79, 125.07, 119.58, 115.29, 41.80, 40.82, 36.75, 34.98, 31.89, 28.28, 28.13; IR (KBr) ν: 1795, 1661, 1612, 1598, 1478, 1412, 1386, 1238, 1160, 1092, 1013, 967, 867, 780, 698 cm-1. HRMS (ESI) calcd for C23H23O4N2 [M+H]+ 391.1652, found 391.1658.
(E)-7, 7-二甲基-4-(噻吩-2-基)-5-(对甲苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3k):黄色固体, 产率81%. m.p. 124.3~124.7 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.11~7.16 (m, 3H), 6.89~6.92 (m, 2H), 6.61~6.63 (m, 2H), 4.85 (d, J=6.8 Hz, 1H), 3.19 (dd, J=16.0, 1H), 3.01 (dd, J=16.0, 7.2 Hz, 1H), 2.32~2.33 (m, 5H), 2.18 (s, 2H), 1.02 (s, 3H), 0.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.3, 162.9, 157.0, 148.4, 144.4, 132.6, 129.5, 126.5, 124.5, 123.4, 119.4, 116.5, 41.0, 40.7, 36.0, 31.6, 30.0, 28.3, 28.1, 20.9; IR (KBr) ν: 1770, 1662, 1625, 1502, 1413, 1375, 1141, 1103, 1032, 967, 865, 828, 741, 702 cm-1. HRMS (ESI) calcd for C22H23O2NNaS [M+Na]+ 388.1347, found 388.1355.
(E)-7, 7-二甲基-4-苯基-5-(对甲苯基亚氨基)- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3l):淡黄色固体, 产率92%. m.p. 95.6~96.0 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.33~7.18 (m, 5H), 7.06 (d, J=8.0 Hz, 2H), 6.46 (d, J=8.2 Hz, 2H), 4.61 (d, J=7.3 Hz, 1H), 3.02 (dd, J=16.1, 7.5 Hz, 1H), 2.94 (d, J=16.1 Hz, 1H), 2.45 (d, J=17.8 Hz, 1H), 2.36 (d, J=16.8 Hz, 1H), 2.30 (s, 3H), 2.20 (d, J=15.5 Hz, 1H), 2.10 (d, J=15.5 Hz, 1H), 1.04 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.5, 162.8, 157.1, 148.6, 141.5, 132.4, 129.4, 128.8, 127.0, 126.9, 119.3, 116.0, 41.1, 40.8, 36.7, 34.6, 31.6, 28.4, 28.0, 20.8; IR (KBr) ν: 1723, 1668, 1623, 1497, 1471, 1457, 1382, 1257, 1230, 1185, 1104, 875, 668 cm-1. HRMS (ESI) calcd for C24H25O2NNa [M+Na]+ 382.1783, found 382.1811.
(E)-5-((4-甲氧基苯基)亚氨基)-7, 7-二甲基-4-苯基- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3m):淡黄色固体, 产率71%. m.p. 95.3~95.9 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.26 (t, J=8.6 Hz, 5H), 6.82 (d, J=8.2 Hz, 2H), 6.51 (d, J=8.1 Hz, 2H), 4.61 (d, J=6.3 Hz, 1H), 3.78 (s, 3H), 3.02 (dd, J=15.9, 7.4 Hz, 1H), 2.94 (d, J=15.8 Hz, 1H), 2.45 (d, J=17.8 Hz, 1H), 2.36 (d, J=17.7 Hz, 1H), 2.22 (d, J=15.4 Hz, 1H), 2.13 (d, J=15.4 Hz, 1H), 1.04 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 166.75, 163.85, 159.04, 157.44, 143.61, 141.10, 128.99, 127.35, 126.79, 125.07, 119.58, 115.29, 41.80, 40.82, 36.75, 34.98, 31.89, 28.28, 28.13; IR (KBr) ν: 1735, 1670, 1633, 1500, 1481, 1460, 1385, 1256, 1228, 1180, 1105, 871, 669 cm-1. HRMS (ESI) calcd for C24H26O3N [M+H]+ 376.1907, found 376.1910.
(E)-4-(4-溴苯基)-5-((4-氯苯基)亚氨基)-7, 7-二甲基- 3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3n):淡黄色固体, 产率65%. m.p.142.9~143.2 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.42 (d, J=8.4 Hz, 2H), 7.23 (d, J=8.6 Hz, 2H), 7.11 (d, J=8.5 Hz, 2H), 6.48 (d, J=6.7 Hz, 2H), 4.53 (d, J=7.5 Hz, 1H), 3.03 (dd, J=16.1, 7.7 Hz, 1H), 2.90 (d, J=16.1 Hz, 1H), 2.45 (d, J=17.9 Hz, 1H), 2.39 (d, J=18.0 Hz, 1H), 2.15 (d, J=15.6 Hz, 1H), 2.08 (d, J=15.6 Hz, 1H), 1.05 (s, 3H), 0.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.1, 162.7, 157.6, 151.0, 140.6, 131.9, 128.9, 128.7, 123.2, 120.9, 119.2, 115.5, 41.1, 40.8, 36.4, 34.3, 31.6, 28.3, 28.1; IR (KBr) ν: 1785, 1632, 1585, 1402, 1210, 1108, 1036, 981, 864, 819 cm-1. HRMS (ESI) calcd for C23H21O2BrClNNa [M+Na]+ 480.0342, found 480.0340.
(E)-5-((4-氯苯基)亚氨基)-7, 7-二甲基-4-(噻吩-2-基)-3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3o):黄色固体, 产率72%. m.p. 120.5~120.9 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.26~7.28 (m, 2H), 7.15 (dd, J=5.2, 1.2 Hz, 1H), 6.89~6.92 (m, 2H), 6.63~6.66 (m, 2H), 4.81 (d, J=6.8Hz, 1H), 3.18 (d, J=16.4, 1H), 3.01 (dd, J=16.4, 7.2 Hz, 1H), 2.34 (s, 2H), 2.15 (s, 2H), 1.03 (s, 3H), 0.98 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 167.0, 163.7, 157.7, 149.6, 144.2, 129.0, 128.6, 126.6, 124.5, 123.4, 120.8, 116.3, 41.1, 40.7, 36.0, 31.7, 30.0, 28.3, 28.0; IR (KBr) ν: 1768, 1654, 1627, 1503, 1375, 1141, 1103, 1030, 957, 846, 825, 744 cm-1. HRMS (ESI) calcd for C21H20O2ClNNaS [M+Na]+ 408.0801, found 408.0812.
(E)-4-苯基-5-(苯基亚氨基)-3, 4, 5, 6, 7, 8-六氢-2H-色烯-2-酮(3p):淡黄色固体, 产率76%. m.p. 90.3~90.7 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.20~7.31 (m, 7H), 7.01 (t, J=7.6 Hz, 1H), 6.57~6.59 (m, 2H), 4.64 (d, J=7.2 Hz, 1H), 3.04 (dd, J=16.4, 7.6 Hz, 1H), 2.95 (d, J=16.4, 1H), 2.50~2.55 (m, 2H), 2.23~2.41 (m, 2H), 1.87~1.94 (m, 2H); 13C NMR (100 MHz, CDCl3) δ: 167.3, 163.2, 159.0, 151.2, 141.4, 128.8, 128.8, 127.1, 126.9, 123.1, 119.4, 117.0, 36.6, 34.6, 27.7, 27.1, 21.0; IR (KBr) ν: 1782, 1659, 1608, 1591, 1484, 1380, 1219, 1169, 1115, 1013, 967, 926, 850, 785, 703 cm-1. HRMS (ESI) calcd for C21H19O2NNa [M+Na]+ 340.1313, found 340.1332.
(E)-5-(苯基亚氨基)-4-(对甲苯基)-3, 4, 5, 6, 7, 8-六氢- 2H-色烯-2-酮(3q):淡黄色固体, 产率85%. m.p. 92.7~93.1 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.23 (m, 2H), 7.09~7.15 (m, 4H), 6.99~7.03 (m, 1H), 6.58~6.60 (m, 2H), 4.60 (d, J=7.2 Hz, 1H), 3.02 (dd, J=16.0, 7.6 Hz, 1H), 2.92 (d, J=16.0, 1H), 2.45~2.62 (m, 2H), 2.22~2.40 (m, 5H), 1.86~1.93 (m, 2H); 13C NMR (100 MHz, CDCl3) δ: 167.5, 163.3, 158.8, 151.2, 138.4, 136.6, 129.4, 128.8, 126.8, 123.1, 119.4, 117.2, 36.7, 34.1, 27.8, 27.1, 21.0; IR (KBr) ν: 1781, 1659, 1616, 1592, 1512, 1485, 1377, 1217, 1169, 729, 697 cm-1. HRMS (ESI) calcd for C22H21O2NNa [M+Na]+ 354.1470, found 354.1468.
辅助材料(Supporting Information) 化合物3a~3q的1H NMR和13C NMR谱图.这些材料可以免费从本刊网站(http://sioc-journal.cn/)上下载.
-
-
[1]
(a) He, Z.; Qi, X.; She, Z.; Zhao, Y.; Li, S.; Tang, J.; Gao, G.; Lan, Y.; You, J. J. Org. Chem. 2017, 82, 1403.
(b) Maddox, S. M.; Dinh, A. N.; Armenta, F.; Um, J.; Gustafson, J. L. Org. Lett. 2016, 18, 5476.
(c) Hyster, T. K.; Farwell, C. C.; Buller, A. R.; McIntosh, J. A.; Arnold, F. H. J. Am. Chem. Soc. 2014, 136, 15505.
(d) Hernández-Torres, J. M.; Achkar, J.; Wei, A. J. Org. Chem. 2004, 69, 7206.
(e) Trost, B. M.; Rudd, M. T.; Costa, M. G.; Lee, P. I.; Pomerantz, A. E. Org. Lett. 2004, 6, 4235.
(f) Kim, H. Y.; Lee, S.; Kim, S.; Oh, K. Org. Lett. 2015, 17, 450. -
[2]
Kao, T.; Peng, B.; Liang, M.; Lee, C.; Chen, I.; Shia, K.; Wu, Y. J. Org. Chem. 2018, 83, 14688. doi: 10.1021/acs.joc.8b01866
-
[3]
Pagire, S. K.; Hossain, A.; Reiser, O. Org. Lett. 2018, 20, 648. doi: 10.1021/acs.orglett.7b03790
-
[4]
Li, X.; Wang, S.; Li, S.; Li, K.; Mo, X.; Liu, L.; Chang, W.; Li, J. J. Org. Chem. 2019, 84, 1288. doi: 10.1021/acs.joc.8b02730
-
[5]
(a) Enders, D.; Niemeier, O.; Henseler, A. Chem. Rev. 2007, 107, 5606.
(b) Nair, V.; Menon, R. S.; Biju, A. T.; Sinu, C. R.; Paul, R. R.; Jose, A.; Sreekumar, V. Chem. Soc. Rev. 2011, 40, 5336.
(c) Wang, T.; Ye, S. Sci. Chin. Chem. 2011, 41, 1306.
(d) Menon, R. S.; Biju, A. T.; Nair, V. Beilstein J. Org. Chem. 2016, 12, 444.
(e) Sun, X. Y.; Wu, J. Chin. J. Org. Chem. 2006, 26, 745(in Chinese).
(孙小宇, 吴劼, 有机化学, 2006, 26, 745.)
(f) Vora, H. U.; Wheeler, P.; Rovis, T. Adv. Synth. Catal. 2012, 354, 1617.
(g) Qu, M. N.; He, J. M. Chin. J. Org. Chem. 2011, 31, 1388(in Chinese).
(屈孟男, 何金梅, 有机化学, 2011, 31, 1388.)
(h) Bugaut, X.; Glorius, F. Chem. Soc. Rev. 2012, 41, 3511.
(i) Izquierdo, J.; Hutson, G. E.; Cohen, D. T.; Scheidt, K. A. Angew. Chem., Int. Ed. 2012, 51, 11686.
(j) Ye, M.; Shen, P. P.; Duan, W. Z.; Song, C.; Ma, Y. D. Chin. J. Org. Chem. 2017, 37, 2919(in Chinese).
(叶梦, 申盼盼, 段文增, 宋淳, 马玉道, 有机化学, 2017, 37, 2919.)
(k) Sun, L. H.; Liang, Z. Q.; Ye, S. Acta Chim. Sinica 2014, 72, 841(in Chinese).
(孙利辉, 梁志钦, 叶松, 化学学报, 2014, 72, 841.)
(l) Hopkinson, M. N.; Richter, C.; Schedler, M.; Glorius, F. Nature 2014, 510, 485.
(m) Yu, F. L.; Lu, Y. Q.; Yuan, B.; Xie, C. X.; Yu, S. T. Chin. J. Org. Chem. 2015, 35, 2223(in Chinese).
(于凤丽, 鲁玉倩, 袁冰, 解从霞, 于世涛, 有机化学, 2015, 35, 2223.)
(n) Wang, A.; Xiao, Y. L.; Zhou, J. Y.; Xu, J.; Liu, H. Chin. J. Org. Chem. 2017, 37, 2590(in Chinese).
(王翱, 肖永龙, 周宇, 徐进宜, 柳红, 有机化学, 2017, 37, 2590.)
(o) Ju, L.; Ma, C. M.; Tang, M.; Wang, Y. H.; Yu, X. H.; Ma, H. M. Chin. J. Org. Chem. 2018, 38, 3056(in Chinese).
(巨磊, 马春梅, 唐蜜, 王妍卉, 虞心红, 马红梅, 有机化学, 2018, 38, 3056.)
(p) Zhang, J.; Du, G. F.; Gu, C. Z.; Dai, B. Chin. J. Org. Chem. 2017, 37, 914(in Chinese).
(张洁, 杜广芬, 顾承志, 代斌, 有机化学, 2017, 37, 914.)
(q) Wang, L. M.; Wang, Q.; Chen, J. A.; Huang, Y. Acta Chim Sinica 2018, 76, 850(in Chinese).
(王乐明, 王骞, 陈杰安, 黄湧, 化学学报, 2018, 76, 850.) -
[6]
(a) Mukherjee, S.; Mondal, S.; Patra, A.; Gonnade, R. G.; Biju, A. T. Chem. Commun. 2015, 51, 9559.
(b) Chen. J. Huang, Y. Nat. Commun. 2014, 5, 3437.
(c) Huang, X. L.; He, L.; Shao. P. L.; Ye, S. Angew. Chem., Int. Ed. 2009, 48, 192;
(d) Wang, Y.; Wu, B.; Zheng, L.; Wei, D.; Tang, M. Org. Chem. Front. 2016, 3, 190.
(e) Que, Y.; Li, T.; Yu, C.; Wang, X. S.; Yao, C. J. Org. Chem. 2015, 80, 3289. -
[7]
(a) Zhang, C.; Hooper, J. F.; Lupton, D. W. ACS Catal. 2017, 7, 2583.
(b) Mahatthananchai, J.; Bode, J. W. Acc. Chem. Res. 2014, 47, 696.
(c) Levens, A.; Lupton, D. W. Synlett 2017, 28, 415.
(d) Flanigan, D. M.; Romanov-Michailidis, F.; White, N. A.; Rovis, T. Chem. Rev. 2015, 115, 9307.
(e) Ryan, S. J.; Candish, L.; Lupton, D. W. Chem. Soc. Rev. 2013, 42, 4906.
(f) Reyes, E.; Uria, U.; Carrillo, L.; Vicario, J. L. Synthesis 2017, 49, 451. -
[8]
(a) Lu, H.; Liu, J.-Y.; Li, C.-G.; Lin, J.-B.; Liang, Y.-M.; Xu, P.-F. Chem. Commun. 2015, 51, 4473.
(b) Xu, J.; Jin, Z.; Chi, Y. R. Org. Lett. 2013, 15, 5028.
(c) Cheng, J.; Huang, Z.; Chi, Y. R. Angew. Chem., Int. Ed. 2013, 52, 8592.
(d) Candish, L.; Lupton, D. W. J. Am. Chem. Soc. 2013, 135, 58.
(e) Yao, C.; Wang, D.; Lu, J.; Li, T.; Jiao, W.; Yu, C. Chem. Eur. J. 2012, 18, 1914.
(f) Sun, F.-G.; Sun, L.-H.; Ye, S. Adv. Synth. Catal. 2011, 353, 3134.
(g) Xie, Y.; Que, Y.; Li, T.; Zhu, L.; Yu, C.; Yao, C. Org. Biomol. Chem. 2015, 13, 1829.
(h) Qiao, Y.; Wei, D.; Chang, J. J. Org. Chem. 2015, 80, 8619. -
[9]
Yao, C.; Jiao, W.; Xiao, Z.; Liu, R.; Li, T.; Yu, C. Tetrahedron 2013, 69, 1133. doi: 10.1016/j.tet.2012.11.052
-
[10]
(a) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70, 461.
(b) Yan, F.; Liu, Y.; Wang, W. Tumor Biol. 2013, 34, 2135.
(c) Wei, J.; Liu, M.; Liu, H.; Wang, H.; Wang, F.; Zhang, Y.; Han, L.; Lin, X. J. Appl. Toxicol. 2013, 33, 756.
(d) Yeom, H.-S.; Li, H.; Tang, Y.; Hsung, R. P. Org. Lett. 2013, 15, 3130. -
[11]
(a) Que, Y.; Li, T.; Yu, C.; Wang, X.-S.; Yao, C. J. Org. Chem. 2015, 80, 3289.
(b) Que, Y.; Lu, Y.; Wang, W.; Wang, Y.; Wang, H.; Yu, C.; Li, T.; Wang, X.-S.; Shen, S.; Yao, C. Chem. Asian J. 2016, 11, 678.
(c) Que, Y.; Xie, Y.; Li, T.; Yu, C.; Tu, S.; Yao, C. Org. Lett. 2015, 17, 6234.
(d) Wang, Y.; Pan, J.; Dong, J.; Yu, C.; Li, T.; Wang, X.-S.; Shen, S.; Yao, C. J. Org. Chem. 2017, 82, 1790.
(e) Yu, C.; Shen, S.; Jiang, L.; Li, J.; Lu, Y.; Li, T.; Yao, C. Org. Biomol. Chem. 2017, 15, 9149.
(f) Hu, Y.; Pan, D.; Cong, L.; Yao, Y.; Yu, C.; Li, T.; Yao, C. ChemistrySelect 2018, 3, 1708.
(g) Li, S.; Yao, Y.; Tang, Z.; Sun, B.; Yu, C.; Li, T.; Yao, C. Org. Biomol. Chem. 2019, 17, 268. -
[12]
CCDC No. 1894520(3a). The crystallographic data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
-
[13]
(a) Samanta, R. C.; Maji, B.; De Sarkar, S.; Bergander, K.; Fröhlich, R.; Mück-Lichtenfeld, C.; Mayr, H.; Studer, A. Angew. Chem., Int. Ed. 2012, 51, 5234.
(b) Domingo, L. R.; Sáez, J. A.; Arnó, M. Org. Biomol. Chem. 2014, 12, 895.
(c) Aurell, M. J.; Domingo, L. R.; Arno, M.; Zaragoza, R. J. Org. Biomol. Chem. 2016, 14, 8338.
(d) Wang, Y.; Wu, B.; Zheng, L.; Wei, D.; Tang, M. Org. Chem. Front. 2016, 3, 190.
(e) Wang, Y.; Wei, D.; Wang, Y.; Zhang, W.; Tang, M. ACS Catal. 2016, 6, 279.
(f) Wang, Y.; Wei, D.; Zhang, W. ChemCatChem 2018, 10, 338.
(g) Wang, J.; Li, Y.; Sun, J.; Wang, H.; Jin, Z.; Chi, Y. R. ACS Catal. 2018, 8, 9859.
(h) Mondal, S.; Yetra, S. R.; Mukherjee, S.; Biju, A. T. Acc. Chem. Res. 2019, 52, 425. -
[14]
(a) Kowalski, C. J.; Weber, A. E.; Fields, K. W. J. Org. Chem. 1982, 47, 5088.
(b) Dommaraju, Y.; Borthakur, S.; Rajesh, N.; Prajapati, D. RSC Adv. 2015, 5, 24327.
-
[1]
-
表 1 合成吡喃酮类化合物的反应条件优化a
Table 1. Reaction optimization for the syntheses of pyranone

Entry NHC Base Solvent T/℃ Yieldb/% of 3a Yieldb/% of 4a 1 None Cs2CO3 Toluene 25 — — 2 A Cs2CO3 Toluene 25 Trace — 3 B Cs2CO3 Toluene 25 40 — 4 C Cs2CO3 Toluene 25 14 — 5 D Cs2CO3 Toluene 25 21 — 6 E Cs2CO3 Toluene 25 Trace — 7 B K2CO3 Toluene 25 32 — 8 B CH3COONa Toluene 25 — — 9 B KOBu-t Toluene 25 20 — 10 B DABCO Toluene 25 — — 11 B DBU Toluene 25 — — 12 B Et3N Toluene 25 — — 13 B Cs2CO3 THF 25 55 — 14 B Cs2CO3 CH2Cl2 25 12 — 15 B Cs2CO3 1, 4-Dixoane 25 Trace — 16 B Cs2CO3 Toluene 15 53 — 17 B Cs2CO3 Toluene 35 67 — 18 B Cs2CO3 Toluene 45 41 Trace 19 B Cs2CO3 Toluene 55 29 41 a All reactions were performed by using 1.2 equiv. of 1a (0.24 mmol), 1.0 equiv. of 2a (0.2 mmol) in the presence of NHC (20 mol%), and 120 mol% of base in solvent (3 mL) under N2. b Isolated yield. 表 2 NHC催化下吡喃酮的合成a
Table 2. NHC-catalyzed syntheses of pyranone

Entry R1 R2 R3 Product Yield a/% 1 Ph Me Ph 3a 75 2 4-CH3C6H4 Me Ph 3b 94 3 4-OCH3C6H4 Me Ph 3c 88 4 4-BrC6H4 Me Ph 3d 73 5 Thienyl Me Ph 3e 79 6 Furanyl Me Ph 3f 70 7 4-CH3C6H4 Me 4-CH3C6H4 3g 96 8 4-CH3C6H4 Me 4-ClC6H4 3h 85 9 4-BrC6H4 Me 4-CH3C6H4 3i 80 10 Ph Me 4-NO2C6H4 3j 66 11 Thienyl Me 4-CH3C6H4 3k 81 12 Ph Me 4-CH3C6H4 3l 92 13 Ph Me 4-OCH3C6H4 3m 71 14 4-BrC6H4 Me 4-ClC6H4 3n 65 15 Thienyl Me 4-ClC6H4 3o 72 16 Ph H Ph 3p 76 17 4-CH3C6H4 H Ph 3q 85 a All reactios were performed by using 1.2 equiv. of 1 (0.24 mmol), 1.0 equiv. of 2 (0.2 mmol), in the presence of B (20 mol%), and 120 mol% of Cs2CO3 in toluene (3 mL) at 35 ℃ under N2. b Isolated yield by column chromatography. -
扫一扫看文章
计量
- PDF下载量: 27
- 文章访问数: 2546
- HTML全文浏览量: 409

下载:
下载:
下载: